Inventor

GOODWIN RAYMOND G

US40 patents

⚠️ This page may combine multiple inventors who share the name “GOODWIN RAYMOND G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GOODWIN RAYMOND G

IMMUNEX CORP

Method for suppressing inflammatory responses by administering TNFR

Cytokine that induces apoptosis

DNA encoding a cytokine that induces apoptosis

DNA encoding tumor necrosis factor-α and -β receptors

Cytokine designated 4-1BB ligand antibodies and human receptor that binds thereto

DNA encoding tumor necrosis factor-α and -β receptors

CD30 ligand

Cytokine which is a ligand for OX40

Interleukin-7

DNA encoding tumor necrosis factor-α and -β receptors

Cytokine designated 4-IBB ligand

Antibodies to human 4-1BB

Purified p75 (type II) tumor necrosis factor receptor polypeptides

Antibodies directed against CD30 ligand

CD27 ligand

Isolated viral protein TNF antagonists

Antibodies which specifically bind to TNF-R

Antibodies directed against trail

CD30 ligand oligomers and polypeptides

Antibodies to interleuken-7 receptors

Interleukin-7

Interleukin-7 receptors

Use of TRAIL polypeptides to induce apoptosis

Glycoproteins which bind to TNF

Viral proteins capable of binding LAR

Isolated poxvirus A53R-equivalent tumor necrosis factor antagonists

4-1BB polypeptides and DNA encoding 4-1BB polypeptides

CD30 ligand

Cytokine which is a ligand for OX40

CD30 ligand conjugates

Dna encoding interleukin-7 receptors and methods of use

DNA encoding a soluble fragment of TRAIL polypeptide

CD30 ligand

Receptor that causes cell death and recombinant production thereof

STERLING WINTHROP INC

Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors

Antibodies that are immunoreactive with interleukin-7

(unassigned)

Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)

SANOFI SYNTHELABO

Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors

SANOFI SA

Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors

GOODWIN RAYMOND G

Methods of use of the TACI/TACI-L interaction